- Home
- MRVI vs PSNYW Comparison
MRVI vs PSNYW Comparison
Compare MRVI & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- PSNYW
- Stock Information
- Founded
- MRVI 2014
- PSNYW 2017
- Country
- MRVI United States
- PSNYW Sweden
- Employees
- MRVI N/A
- PSNYW 2547
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- PSNYW Auto Manufacturing
- Sector
- MRVI Health Care
- PSNYW Consumer Discretionary
- Exchange
- MRVI Nasdaq
- PSNYW Nasdaq
- Market Cap
- MRVI 312.4M
- PSNYW 338.9M
- IPO Year
- MRVI 2020
- PSNYW N/A
- Fundamental
- Price
- MRVI $2.67
- PSNYW $0.17
- Analyst Decision
- MRVI Hold
- PSNYW
- Analyst Count
- MRVI 10
- PSNYW 0
- Target Price
- MRVI $6.84
- PSNYW N/A
- AVG Volume (30 Days)
- MRVI 1.9M
- PSNYW 43.4K
- Earning Date
- MRVI 08-06-2025
- PSNYW 03-06-2025
- Dividend Yield
- MRVI N/A
- PSNYW N/A
- EPS Growth
- MRVI N/A
- PSNYW N/A
- EPS
- MRVI N/A
- PSNYW N/A
- Revenue
- MRVI $241,856,000.00
- PSNYW $2,034,261,000.00
- Revenue This Year
- MRVI N/A
- PSNYW N/A
- Revenue Next Year
- MRVI $10.62
- PSNYW $79.49
- P/E Ratio
- MRVI N/A
- PSNYW N/A
- Revenue Growth
- MRVI N/A
- PSNYW N/A
- 52 Week Low
- MRVI $1.67
- PSNYW $0.09
- 52 Week High
- MRVI $10.03
- PSNYW $0.61
- Technical
- Relative Strength Index (RSI)
- MRVI 59.30
- PSNYW 60.55
- Support Level
- MRVI $2.52
- PSNYW $0.15
- Resistance Level
- MRVI $2.93
- PSNYW $0.18
- Average True Range (ATR)
- MRVI 0.18
- PSNYW 0.01
- MACD
- MRVI 0.03
- PSNYW 0.00
- Stochastic Oscillator
- MRVI 69.41
- PSNYW 60.43
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.